RhumbLine Advisers’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-11
Closed -$59K 2957
2017
Q1
$59K Buy
11
+4
+57% +$21.5K ﹤0.01% 2815
2016
Q4
$46K Sell
7
-2
-22% -$13.1K ﹤0.01% 2830
2016
Q3
$140K Buy
9
+1
+13% +$15.6K ﹤0.01% 2759
2016
Q2
$126K Buy
+8
New +$126K ﹤0.01% 2876